The funding committees for the NIHR Invention for Innovation (i4i) Programme are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members. i4i has five committees: three for Product Development Awards (committee A, committee B and committee C), one for Challenge Awards, and one for Connect.
Committee members - Challenge Awards
|Professor Nick Lemoine (Chair)
|Director, Medical Director
|Barts Cancer Institute,
NIHR Clinical Research Network
|Professor Lemoine is a world leader in pancreatic cancer research and has interest in the development of oncolytic virotherapy and cancer vaccines.
|Ms Joanna Smart (Deputy Chair)
Ms Smart has been active in the life sciences sector for over 20 years, as a CEO, non-executive chair and board director with experience in operating roles in SMEs, startups, global biotech, and investment banking.
Mr Michael Duffin
Director of Client Success
Inicio Health LTD
Mr Duffin has a clinical background in physiotherapy, and a commercial background with experience in pathway transformation, real world evaluation, and digital health.
|Associate professor Iain Hennessey
|Clinical Director of Innovation
|Alder Hay Children’s NHS Foundation Trust
|Dr Hennessey is a consultant paediatric and neonatal surgeon with expertise in surgical simulation and clinical innovation.
|Dr Zarnie Khadjesari
|Associate Professor in Health Sciences
|University of East Anglia
|Dr Khadjesari has expertise in digital health research and implementation science. She is experienced in both quantitative and qualitative research methods.
|Mr Stuart Mealing
|Associate Director (Health Economics and Outcomes Research)
|York Health Economics Consortium Ltd
|Mr Mealing has experience in the development and review of cost-effectiveness and budget impact models and working with medical devices and the modelling of orphan/ultra-orphan conditions.
|Professor Steve Morris
|Ingram Networks Ltd
|Professor Morris has experience in the development of medical devices from concept to regulatory approval and first human use.
|Ms Stella O'Brien
|Public Committee Member
|Mr Sebastian Orton
|Penningtons Manches Cooper LLP
|Mr Orton is a corporate finance lawyer with specific expertise in equity capital markets and raising finance for companies in the life sciences sector
|Professor Amar Rangan
|Professor of Orthopaedic Surgery
|Universities of York and Oxford
|Professor Rangan is a specialist shoulder and elbow surgeon and has experience in clinical effectiveness and translational research.
|Dr Chris Sampson
Senior Principal Economist
Office of Health Economics
Dr Sampson is an expert in health economic evaluation, with a particular interest in mental health and digital therapeutics.
|Professor Wendy Tindale
|Sheffield Teaching Hospitals; NIHR Devices for Dignity MIC
|Professor Tindale is a Consultant Medical Physicist and is experienced in collaborative MedTech development and NHS implementation